Abbott pays $385 million to settle Justice Department claims
The payment resolves 2022 infant formula recall lawsuits without admitting liability and concludes a closed criminal investigation. Regulatory tests showed negative results for pathogens.
Latest Pharmaceuticals News
Stay informed with the latest news and media coverage for the biggest companies in Pharmaceuticals. We track all announcements, press releases, and industry mentions in real time, all in one place. Looking for another sector? Browse our industry database.
Last updated
Latest news in Pharmaceuticals
Company announcements
Definium Therapeutics reports positive Phase 3 Panorama study results for DT120 in GAD
The trial met all efficacy endpoints with significant anxiety reduction. Pre-NDA meetings are scheduled for Q4 2026 to advance toward NDA filing.
Sanofi partners with Cheplapharm to divest mature medicines for equity stake
Cheplapharm acquires 20 mature drugs and three manufacturing sites. Sanofi receives a 26.4% equity stake in the German company, facilitating transaction completion by Q3 2027.
Teva lists ordinary shares directly on NYSE
The direct listing broadens investor access and supports the Pivot to Growth strategy alongside strong financial performance
Unlock all announcements with a free trial
Media coverage
Abbott to pay $384 million over contaminated infant formula allegations, US Justice Dept says
Abbott Laboratories has agreed to pay more than $384 million to settle allegations related to contaminated infant formula, the U.S. Justice Department said on Monday.
GSK's Jideytro & Ris-Rez Show Positive Data In Two Lung Cancer Studies
GSK reported encouraging clinical data for two investigational lung cancer treatments: Jideytro demonstrated high efficacy in first-line ROS1-positive non-small cell lung cancer, while Ris-Rez ...
Organon Announces US FDA Has Accepted for Review a Supplemental New Drug Application for MIUDELLA®, a Hormone-Free Intrauterine Device
JERSEY CITY, N.J.--(BUSINESS WIRE)--Sep 14, 2026...
AstraZeneca's TAGRISSO Achieves 8-Year Survival Milestone In Early-Stage EGFR-...
AstraZeneca's (AZN) TAGRISSO (osimertinib) delivered an unprecedented eight-year landmark overall survival benefit in early-stage EGFR-mutated non-small cell lung cancer (NSCLC), marking the ...
Unlock all articles with a free trial
Track Every Market Move
Follow your target companies and get daily news updates delivered straight to your inbox
Start free trialPharmaceuticals companies
Browse the top companies in Pharmaceuticals and stay on top of their latest developments.
A
- AB Science
- Abarceo Pharma (Abarceo)
- Abbott
- AbbVie
- Abcuro
- Abliva
- Acelot
- Active Biotech
- Advanz Pharma
- Agenus
- Agomab Therapeutics (Agomab)
- Akero Therapeutics (Akero)
- Aktis Oncology
- AL-S Pharma
- Allarity Therapeutics (Allarity)
- Alligator Bioscience (Alligator)
- Alsonex Pharmaceuticals (Alsonex)
- Altimmune
- AlzeCure Pharma
- Alzinova
- Amylyx Pharmaceuticals (Amylyx)
- Annexin Pharmaceuticals
- Anocca
- Apothékary
- Aprea Therapeutics
- argenx
- Ascelia Pharma
- AstraZeneca
- AtaiBeckley
- Aura Biosciences
- Avidity Biosciences
- Axoltis
B
C
- Calico
- Camurus
- Can-Fite BioPharma (Can-Fite)
- Candel Therapeutics (Candel)
- Capricor Therapeutics (Capricor)
- Celosia Therapeutics (Celosia)
- Cencora
- Charles River Laboratories (Charles River)
- Cinclus Pharma
- Clene Inc. (Clene)
- Compass Pathways (Compass)
- Compugen
- Contract Pharma Solutions
- Coya Therapeutics
- CRISPR Therapeutics
- CTS Ltd (CTS)